Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/10/25 16:56 | 12/9/25 | SNSE | Health | Drug | Pharmaceutical Preparations | Cambrian Biopharma Inc | NY | T | S.d | -55 | 8.25 | 0 | -7 | -4 | 155 | D | |||||||||||||||
12/10/25 16:52 | 12/8/25 | SNSE | Health | Drug | Pharmaceutical Preparations | Peyer James | NY | TH | See rema | S.dm | -55 | 8.25 | 0 | -7 | -4 | 155 | I | ||||||||||||||
12/8/25 16:39 | 12/4/25 | SNSE | Health | Drug | Pharmaceutical Preparations | Cambrian Biopharma Inc | NY | T | S.m | -233 | 10.93 | 0 | -21 | -12 | 161 | D | |||||||||||||||
12/8/25 16:36 | 12/4/25 | SNSE | Health | Drug | Pharmaceutical Preparations | Peyer James | NY | TH | See rema | S.m | -233 | 10.93 | 0 | -21 | -12 | 161 | I | ||||||||||||||
6/2/23 17:03 | 6/1/23 | SNSE | Health | Drug | Pharmaceutical Preparations | Apeiron Investment Group Ltd. | O1 | T | S | -5,438 | 1.58 | 0 | -3,442 | -100 | 0 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |